Despite a sombre financial performance in FY24, TCPL’s stock gained 43 per cent during the financial year. The valuation expanded to a PE of 19.55 and a PBV of 3.72. Normally, a stock’s price is expected to underperform during periods of declining operating profitability, unless the stock is undervalued. In other words, it is reasonable (and justified) for a stock to deliver superior returns even during periods of declining profitability if the stock was undervalued in the first place.
Category: Stock Analysis
Discuss the investment prospect of individual stocks based on the analysis and valuation of the stock’s fundamentals
Buy into Uncertainty
This edition of our analysis, dated 19 June 2024, discusses the investment prospects of these stocks: Dynemic Products, RACL Geartech, and Kovai Medical Center.
Implications of Leaving Ultra-low Interest Rates
"Interest rates play a crucial role in shaping economic and financial conditions, influencing spending, saving, and investment behaviour. As we transition from ultra-low interest rate environments, it's crucial to consider the long-term consequences of these changes on asset prices and the overall economic prosperity."
Choosing the Right Stock for Your Portfolio
Investing based on recent stock performance is ineffective. Instead, focus on a stock's expected profitability and earnings power. This method may increase your odds of achieving superior returns. Read on to Know More...
Stock Review: Dynemic Products
The stock market can be a rollercoaster ride, with many ups and downs. Dynemic Products is no exception, with its stock experiencing significant price drops in recent years. In this stock review, we'll explore the investment prospects of Dynemic Products and discuss whether it's worth investing in this company. So, let's dive in and see what opportunities and challenges lie ahead for investors.
Revisiting Natural Capsules: Is It Worth the Risk Now?
The current state of Natural Capsules' stock, its core fundamentals, and its valuation; insights for potential investors to make an informed decision. Briefing Since peaking at ₹638.95 per share on 9 Sep. 2022, the stock of Natural Capsules has been in a long decline during which it lost 50 per cent in value over one-and-half … Continue reading Revisiting Natural Capsules: Is It Worth the Risk Now?
How to Beat the Market
Identify High-Risk Stocks That Are More Likely to Get Re-Rated, and for that, Focus on Core Fundamentals. “In the short run, the market is a voting machine. In the long run, it is a weighing machine.” Benjamin Graham “Beating the Market”: earning an investment return greater than the return of benchmark indices such as Sensex, … Continue reading How to Beat the Market
Is Ador Fontech Stock a Buy or Sell?
Analysing ADFL's Financials and Valuation to Determine its Investment Prospects The stock of Ador Fontech trades at ₹140 per share – 11 per cent off its all-time high of ₹157.20 per share attained on 5 Jan. 2024. The stock has delivered superior returns over the past five years – 21.16 per cent annually. On a … Continue reading Is Ador Fontech Stock a Buy or Sell?
Gandhi Special Tubes: No Tailwinds, No Headwinds Either
"Examining the Risks and Rewards of Investing in the Stock of a Niche Manufacturing Company" Firstly, for the benefit of the uninitiated, a brief introduction to the stock: Gandhi Special Tubes principally manufactures a niche product – small-diameter seamless steel tubes that are supplied to the original equipment manufacturers (OEMs) in the automotive, farm equipment, … Continue reading Gandhi Special Tubes: No Tailwinds, No Headwinds Either
Star Cement: Is it Worth Investing Now?
Scrutinising Star Cement's Recent Outstanding Performance, Current Valuation, and Investment Prospects The stock of Star Cement gained 10.54 per cent on 22 Mar. 2024 – and closed the day at ₹232 per share – making a new all-time high. The stock now trades at ₹230.60 per share. One-and-a-half years ago, in Sep. 2022, it was … Continue reading Star Cement: Is it Worth Investing Now?









